Since 90% of cancer mortality results from metastatic lesions [105] and over 50% of neuroblastoma patients especially those are older than 1 year of age with MYCN amplification present wide-spread metastasis at diagnosis [106], it is important to understand the pathogenesis of neuroblastoma metastasis. The gene discussed is MYCN; the disease is neuroblastoma.